In the News
- Retinitis Pigmentosa: Mitigating Retinal Degeneration with CRISPR Technology
- Universal Treatment Approach May Be on Horizon for Retinitis Pigmentosa
- Revitalizing Vision: Metabolome Rejuvenation Can Slow Retinal Degeneration
- Nanoscope Therapeutics announces first patient dosed in STARLIGHT Phase 2 clinical trial of MCO-010 optogenetic gene therapy for Stargardt disease
- Nanoscope Therapeutics announces 3 new appointments to its scientific and clinical advisory boardÂ
- ARVO sets stage for virtual event
- CRISPR used to restore retinal function
- Retinitis pigmentosa may be treated by reprogramming sugar metabolism